Monopar Therapeutics Inc

+0.38 (+8.34%)
Earnings Announcements

Monopar Therapeutics Q4 Loss Per Share $0.19

Published: 03/25/2021 12:08 GMT
Monopar Therapeutics Inc (MNPR) - Monopar Therapeutics Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Business Updates.
Q4 Loss per Share $0.19.
Q4 Earnings per Share Estimate $-0.20 -- Refinitiv Ibes Data (analyst estimates).
Anticipates That Its Current Cash and Cash Equivalents Will Fund Co's Planned Operations at Least Through March 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.21

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.